634 related articles for article (PubMed ID: 16754881)
1. microRNAs exhibit high frequency genomic alterations in human cancer.
Zhang L; Huang J; Yang N; Greshock J; Megraw MS; Giannakakis A; Liang S; Naylor TL; Barchetti A; Ward MR; Yao G; Medina A; O'brien-Jenkins A; Katsaros D; Hatzigeorgiou A; Gimotty PA; Weber BL; Coukos G
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9136-41. PubMed ID: 16754881
[TBL] [Abstract][Full Text] [Related]
2. Are microRNAs located in genomic regions associated with cancer?
Lamy P; Andersen CL; Dyrskjøt L; Tørring N; Ørntoft T; Wiuf C
Br J Cancer; 2006 Nov; 95(10):1415-8. PubMed ID: 17003783
[TBL] [Abstract][Full Text] [Related]
3. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.
Naylor TL; Greshock J; Wang Y; Colligon T; Yu QC; Clemmer V; Zaks TZ; Weber BL
Breast Cancer Res; 2005; 7(6):R1186-98. PubMed ID: 16457699
[TBL] [Abstract][Full Text] [Related]
4. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
[TBL] [Abstract][Full Text] [Related]
5. Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.
Lionetti M; Agnelli L; Mosca L; Fabris S; Andronache A; Todoerti K; Ronchetti D; Deliliers GL; Neri A
Genes Chromosomes Cancer; 2009 Jun; 48(6):521-31. PubMed ID: 19306352
[TBL] [Abstract][Full Text] [Related]
6. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP
Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250
[TBL] [Abstract][Full Text] [Related]
7. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
8. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA
Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551
[TBL] [Abstract][Full Text] [Related]
9. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
11. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Zhang L; Volinia S; Bonome T; Calin GA; Greshock J; Yang N; Liu CG; Giannakakis A; Alexiou P; Hasegawa K; Johnstone CN; Megraw MS; Adams S; Lassus H; Huang J; Kaur S; Liang S; Sethupathy P; Leminen A; Simossis VA; Sandaltzopoulos R; Naomoto Y; Katsaros D; Gimotty PA; DeMichele A; Huang Q; Bützow R; Rustgi AK; Weber BL; Birrer MJ; Hatzigeorgiou AG; Croce CM; Coukos G
Proc Natl Acad Sci U S A; 2008 May; 105(19):7004-9. PubMed ID: 18458333
[TBL] [Abstract][Full Text] [Related]
12. An integrated approach to reveal miRNAs' impacts on the functional consequence of copy number alterations in cancer.
Li K; Liu Y; Zhou Y; Zhang R; Zhao N; Yan Z; Zhang Q; Zhang S; Qiu F; Xu Y
Sci Rep; 2015 Jun; 5():11567. PubMed ID: 26099552
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
14. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.
Pinkel D; Segraves R; Sudar D; Clark S; Poole I; Kowbel D; Collins C; Kuo WL; Chen C; Zhai Y; Dairkee SH; Ljung BM; Gray JW; Albertson DG
Nat Genet; 1998 Oct; 20(2):207-11. PubMed ID: 9771718
[TBL] [Abstract][Full Text] [Related]
15. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
16. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
[TBL] [Abstract][Full Text] [Related]
17. Genomic DNA copy-number alterations of the let-7 family in human cancers.
Wang Y; Hu X; Greshock J; Shen L; Yang X; Shao Z; Liang S; Tanyi JL; Sood AK; Zhang L
PLoS One; 2012; 7(9):e44399. PubMed ID: 22970210
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma.
Sung CO; Choi CH; Ko YH; Ju H; Choi YL; Kim N; Kang SY; Ha SY; Choi K; Bae DS; Lee JW; Kim TJ; Song SY; Kim BG
Cancer Genet; 2013 May; 206(5):145-53. PubMed ID: 23726144
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA expression profiling in prostate cancer.
Porkka KP; Pfeiffer MJ; Waltering KK; Vessella RL; Tammela TL; Visakorpi T
Cancer Res; 2007 Jul; 67(13):6130-5. PubMed ID: 17616669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]